Conformis,Inc. (NASDAQ:CFMS) Files An 8-K Results of Operations and Financial Condition
Item 2.02
Results of Operations and Financial Condition
On January 8, 2019, Conformis, Inc. issued a press release announcing its selected preliminary unaudited financial results for the quarter and fiscal year ended December 31, 2018. A copy of such press release is attached as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by reference in its entirety.
The information furnished under this Item 2.02, including the press release attached hereto, shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933 or the Exchange Act, except as otherwise expressly stated in such filing.
|
Item 9.01 |
Financial Statements and Exhibits |
*Furnished herewith
Conformis Inc Exhibit
EX-99.1 2 pr01082019-01.htm EXHIBIT 99.1 Exhibit Conformis Reports Preliminary Fourth Quarter and Year-End 2018 Revenue ResultsBILLERICA,…
To view the full exhibit click here
About Conformis,Inc. (NASDAQ:CFMS)
ConforMIS, Inc. is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee. Its iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery. The Company markets and sells its products in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore and Hong Kong.
